Skip to main content
Top
Published in: Journal of Thrombosis and Thrombolysis 1/2020

01-01-2020

Pulmonary embolism response team implementation improves awareness and education among the house staff and faculty

Authors: Yevgeniy Brailovsky, Siri Kunchakarra, Vladimir Lakhter, Geoffrey Barnes, Dalila Masic, Erin Mancl, Katerina Porcaro, Carlos F. Bechara, John J. Lopez, Kevin Simpson, Verghese Mathew, Jawed Fareed, Amir Darki

Published in: Journal of Thrombosis and Thrombolysis | Issue 1/2020

Login to get access

Abstract

A subset of high-risk pulmonary embolism (PE) patients requires advanced therapy beyond anticoagulation. Significant variation in delivery of care has led institutions to standardize their approach by developing Pulmonary Embolism Response Team (PERT). We sought to assess the impact of PERT implementation on house staff and faculty education. After implementation of PERT, we employed a targeted educational intervention aimed to improve PERT awareness, familiarity with treatment options, role of echocardiogram and Doppler ultrasound, and knowledge of acute PE risk stratification tools. We conducted an anonymous survey among the house staff and faculty before and after intervention to assess the impact of PERT implementation on educational objectives among clinicians. Initial and follow up samples included 115 and 109 responses. The samples were well represented across the subspecialties and all levels of training, as well as junior and senior faculty. Following the educational campaign, awareness of the program increased (72.2–92.6%, p < 0.01). Proportion of clinicians with reported comfort level of managing PE increased (82.4–90.8%, p = 0.07). Proportion of clinicians with self-reported comfort with explaining all available treatment modalities to patients increased (49.1–67.9%, p = 0.005). Proportions of responders who correctly identified the role of echocardiography in risk stratification of patients with known PE increased (73.9–84.4%, p = 0.07). Accurate clinical risk stratification of acute PE increased (60.2–73.8%, p = 0.03). The implementation of a targeted educational program at a tertiary care center increased awareness of PERT among house staff and faculty and improved physician’s accuracy of clinical risk stratification and comfort level with management of acute PE.
Appendix
Available only for authorised users
Literature
8.
go back to reference Xenos ES, Davis G, Green A, He Q, Smyth S (2018) The implementation of a pulmonary embolism response team in the management of pulmonary embolism. J Vasc Surg 67:e13–e14CrossRef Xenos ES, Davis G, Green A, He Q, Smyth S (2018) The implementation of a pulmonary embolism response team in the management of pulmonary embolism. J Vasc Surg 67:e13–e14CrossRef
Metadata
Title
Pulmonary embolism response team implementation improves awareness and education among the house staff and faculty
Authors
Yevgeniy Brailovsky
Siri Kunchakarra
Vladimir Lakhter
Geoffrey Barnes
Dalila Masic
Erin Mancl
Katerina Porcaro
Carlos F. Bechara
John J. Lopez
Kevin Simpson
Verghese Mathew
Jawed Fareed
Amir Darki
Publication date
01-01-2020
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 1/2020
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-019-01927-5

Other articles of this Issue 1/2020

Journal of Thrombosis and Thrombolysis 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine